Following a December 2022 decision that dismissed tens of thousands of federal lawsuits in the U.S., a provincial high court in Canada dismissed a proposed class-action Zantac lawsuit, Market Watch reported. Plaintiffs alleged that they developed cancer after prolonged usage of the popular, now-discontinued heartburn drug, Zantac. The Supreme Court…